Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuno Taveira

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Scientific Reports|February 24, 2017
Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in AngolaJoão Perdigão, Sofia Clemente, Jorge Ramos, et al.
International Journal of Mycobacteriology|January 4, 2017
Genetic diversity, transmission dynamics, and drug resistance of Mycobacterium tuberculosis in Luanda, AngolaJoão Perdigão, Sofia Clemente, Jorge Ramos, et al.
Retrovirology|September 10, 2008
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patientsPedro Borrego, José Maria Marcelino, Cheila Rocha, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 20, 2008
Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemicInês Bártolo, Cheila Rocha, José Bartolomeu, et al.
AIDS (London, England)|November 5, 2008
Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progressionJosé Maria Marcelino, Charlotta Nilsson, Helena Barroso, et al.
AIDS (London, England)|November 16, 2012
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropismJosé M Marcelino, Pedro Borrego, Charlotta Nilsson, et al.
International Journal of Molecular Sciences|June 26, 2026
Longitudinal Analysis of HIV-2 Proviral DNA Reveals Archived Protease Inhibitor Resistance and Reservoir Evolution over Eight YearsPaloma Gonçalves, Inês Lopes, Andreia Martins, et al.
Scientific Reports|August 5, 2020
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in SpainClaudia Palladino, Ifeanyi Jude Ezeonwumelu, Irene Mate-Cano, et al.
Scientific Reports|August 18, 2018
Epidemic history of hepatitis C virus genotypes and subtypes in PortugalClaudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistanceInês Bártolo, Cheila Rocha, José Bartolomeu, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Scientific Reports|February 24, 2017
Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in AngolaJoão Perdigão, Sofia Clemente, Jorge Ramos, et al.
International Journal of Mycobacteriology|January 4, 2017
Genetic diversity, transmission dynamics, and drug resistance of Mycobacterium tuberculosis in Luanda, AngolaJoão Perdigão, Sofia Clemente, Jorge Ramos, et al.
Retrovirology|September 10, 2008
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patientsPedro Borrego, José Maria Marcelino, Cheila Rocha, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 20, 2008
Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemicInês Bártolo, Cheila Rocha, José Bartolomeu, et al.
AIDS (London, England)|November 5, 2008
Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progressionJosé Maria Marcelino, Charlotta Nilsson, Helena Barroso, et al.
AIDS (London, England)|November 16, 2012
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropismJosé M Marcelino, Pedro Borrego, Charlotta Nilsson, et al.
International Journal of Molecular Sciences|June 26, 2026
Longitudinal Analysis of HIV-2 Proviral DNA Reveals Archived Protease Inhibitor Resistance and Reservoir Evolution over Eight YearsPaloma Gonçalves, Inês Lopes, Andreia Martins, et al.
Scientific Reports|August 5, 2020
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in SpainClaudia Palladino, Ifeanyi Jude Ezeonwumelu, Irene Mate-Cano, et al.
Scientific Reports|August 18, 2018
Epidemic history of hepatitis C virus genotypes and subtypes in PortugalClaudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistanceInês Bártolo, Cheila Rocha, José Bartolomeu, et al.
Pageof 9